Suppr超能文献

疾病经济负担研究中生产力成本的摩擦成本估算与人力资本估算的比较:综述。

Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.

机构信息

Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MS A-19, Atlanta, GA, 30329-4027, USA.

Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA.

出版信息

Appl Health Econ Health Policy. 2018 Dec;16(6):765-778. doi: 10.1007/s40258-018-0416-4.

Abstract

Cost-of-illness (COI) studies often include the 'indirect' cost of lost production resulting from disease, disability, and premature death, which is an important component of the economic burden of chronic conditions assessed from the societal perspective. In most COI studies, productivity costs are estimated primarily as the economic value of production forgone associated with loss of paid employment (foregone gross earnings); some studies include the imputed value of lost unpaid work as well. This approach is commonly but imprecisely referred to as the human capital approach (HCA). However, there is a lack of consensus among health economists as to how to quantify loss of economic productivity. Some experts argue that the HCA overstates productivity losses and propose use of the friction cost approach (FCA) that estimates societal productivity loss as the short-term costs incurred by employers in replacing a lost worker. This review sought to identify COI studies published during 1995-2017 that used the FCA, with or without comparison to the HCA, and to compare FCA and HCA estimates from those studies that used both approaches. We identified 80 full COI studies (of which 75% focused on chronic conditions), roughly 5-8% of all COI studies. The majority of those studies came from three countries, Canada, Germany, and the Netherlands, that have officially endorsed use of the FCA. The FCA results in smaller productivity loss estimates than the HCA, although the differential varied widely across studies. Lack of standardization of HCA and FCA methods makes productivity cost estimates difficult to compare across studies.

摘要

疾病经济负担(COI)研究通常包括因疾病、残疾和过早死亡而导致的生产损失的“间接”成本,这是从社会角度评估慢性病经济负担的一个重要组成部分。在大多数 COI 研究中,生产力成本主要通过与丧失有薪就业相关的生产损失的经济价值来估算(丧失的总收益);一些研究还包括失去的无薪工作的估算价值。这种方法通常被称为人力资本法(HCA),但并不准确。然而,健康经济学家在如何量化经济生产力损失方面尚未达成共识。一些专家认为 HCA 夸大了生产力损失,并提出使用摩擦成本法(FCA),该方法将社会生产力损失估计为雇主在替代失业工人时产生的短期成本。本综述旨在确定 1995-2017 年间发表的使用 FCA 的 COI 研究,无论是否与 HCA 进行比较,并比较使用这两种方法的研究中的 FCA 和 HCA 估算值。我们确定了 80 项完整的 COI 研究(其中 75%的研究重点是慢性病),约占所有 COI 研究的 5-8%。这些研究大多来自加拿大、德国和荷兰这三个正式认可使用 FCA 的国家。FCA 的生产力损失估计值小于 HCA,尽管研究之间的差异很大。HCA 和 FCA 方法缺乏标准化使得生产力成本估算难以在研究之间进行比较。

相似文献

6
The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.加拿大癌症护理的间接成本负担:系统文献综述。
Appl Health Econ Health Policy. 2021 May;19(3):325-341. doi: 10.1007/s40258-020-00619-z. Epub 2020 Dec 24.

引用本文的文献

本文引用的文献

1
Social Cost of Substance Abuse in Russia.俄罗斯药物滥用的社会成本
Value Health Reg Issues. 2014 Sep;4:1-5. doi: 10.1016/j.vhri.2014.03.004. Epub 2014 May 13.
5
The cost of Lyme borreliosis.莱姆病的成本。
Eur J Public Health. 2017 Jun 1;27(3):538-547. doi: 10.1093/eurpub/ckw269.
7
Indirect costs of rheumatoid arthritis.类风湿关节炎的间接成本。
Reumatologia. 2015;53(5):268-75. doi: 10.5114/reum.2015.55830. Epub 2015 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验